OPS
UTHR icon

Orion Portfolio Solutions’s United Therapeutics UTHR Stock Holding History

Orion Portfolio Solutions’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.26M Buy
4,098
+77
+2% +$26.4K 0.01% 955
2024
Q4 		$1.42M Buy
4,021
+735
+22% +$270K 0.01% 866
2024
Q3 		$1.18M Buy
3,286
+1,233
+60% +$417K 0.01% 959
2024
Q2 		$654K Buy
2,053
+147
+8% +$38.9K 0.01% 1184
2024
Q1 		$438K Sell
1,906
-118
-6% -$26.6K ﹤0.01% 1321
2023
Q4 		$468K Sell
2,024
-167
-8% -$38.5K 0.01% 1239
2023
Q3 		$495K Buy
2,191
+511
+30% +$118K 0.01% 1207
2023
Q2 		$371K Buy
1,680
+148
+10% +$32.8K ﹤0.01% 1323
2023
Q1 		$343K Buy
+1,532
New +$378K ﹤0.01% 1291
2020
Q3 		– Sell
-118
Closed -$14K – 1970
2020
Q2 		$14K Sell
118
-8
-6% -$900 ﹤0.01% 1084
2020
Q1 		$12K Buy
126
+80
+174% +$7.6K ﹤0.01% 1012
2019
Q4 		$4K Buy
+46
New +$4.05K ﹤0.01% 1347

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Orion Portfolio Solutions's UTHR Position: Q1 2025 in Review

Orion Portfolio Solutions increased its United Therapeutics (UTHR) stake by 1.9% in Q1 2025, buying an estimated $26.4K and bringing the position to 4,098 shares worth $1.26M. The position accounts for 0.01% of the portfolio, ranked #955.

Orion Portfolio Solutions first reported a position in UTHR in Q4 2019 and has held it in 12 quarters since. The position peaked at $1.42M in Q4 2024. 671 funds tracked by Wall St. Rank hold UTHR as of Q1 2025.

  • Orion Portfolio Solutions held 4,098 shares of United Therapeutics worth $1.26M as of Q1 2025.
  • Orion Portfolio Solutions bought 77 United Therapeutics shares in Q1 2025, an estimated $26.4K.
  • United Therapeutics made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #955 holding.
  • Orion Portfolio Solutions first reported a position in United Therapeutics in Q4 2019 and has held it in 12 quarters since.
  • Orion Portfolio Solutions's United Therapeutics position peaked at $1.42M in Q4 2024.
  • 671 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.